| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.817 | 0.002 | 0.817 | Cyclic AMP phosphodiesterase inhibitor | 0.781 0.002 DBMET00271 0.799 0.002 DBMET00272 0.811 0.002 DBMET00535 0.745 0.003 DBMET00326 0.719 0.003 DBMET00560 | ||
| 0.715 | 0.004 | 0.804 | Bronchodilator | 0.585 0.004 DBMET00271 0.545 0.004 DBMET00272 0.756 0.004 DBMET00535 0.804 0.003 DBMET00326 0.523 0.004 DBMET00560 | DBMET00326 | |
| 0.606 | 0.017 | 0.694 | Toll-Like receptor 7 agonist | 0.619 0.015 DBMET00271 0.561 0.022 DBMET00272 0.585 0.019 DBMET00535 0.694 0.009 DBMET00326 0.607 0.016 DBMET00560 | DBMET00326 | |
| 0.599 | 0.017 | 0.687 | Toll-Like receptor agonist | 0.612 0.016 DBMET00271 0.553 0.023 DBMET00272 0.576 0.02 DBMET00535 0.687 0.009 DBMET00326 0.601 0.017 DBMET00560 | DBMET00326 | |
| 0.583 | 0.003 | 0.583 | Adenosine A1 receptor antagonist | 0.547 0.003 DBMET00271 0.453 0.004 DBMET00272 0.506 0.003 DBMET00535 0.405 0.004 DBMET00326 0.353 0.005 DBMET00560 | ||
| 0.572 | 0.005 | 0.615 | Diuretic | 0.403 0.013 DBMET00271 0.387 0.014 DBMET00272 0.615 0.004 DBMET00535 0.546 0.005 DBMET00326 0.29 0.024 DBMET00560 | DBMET00535 | |
| 0.559 | 0.02 | 0.781 | Vasodilator, peripheral | 0.299 0.097 DBMET00271 0.304 0.095 DBMET00272 0.781 0.004 DBMET00535 0.45 0.04 DBMET00326 0.348 0.074 DBMET00560 | DBMET00535 | |
| 0.534 | 0.003 | 0.534 | Adenosine A2 receptor antagonist | 0.506 0.003 DBMET00271 0.378 0.004 DBMET00272 0.501 0.003 DBMET00535 0.391 0.004 DBMET00326 0.334 0.005 DBMET00560 | ||
| 0.513 | 0.013 | 0.523 | Hypoxia-inducible factor 1 alpha inhibitor | 0.339 0.049 DBMET00271 0.337 0.049 DBMET00272 0.523 0.013 DBMET00535 0.301 0.065 DBMET00326 | DBMET00535 | |
| 0.497 | 0.002 | 0.497 | Adenosine A2b receptor antagonist | 0.496 0.002 DBMET00271 0.384 0.003 DBMET00272 0.426 0.003 DBMET00535 0.44 0.003 DBMET00326 0.385 0.003 DBMET00560 | ||
| 0.487 | 0.003 | 0.487 | Adenosine A2a receptor antagonist | 0.449 0.003 DBMET00271 0.323 0.005 DBMET00272 0.465 0.003 DBMET00535 0.306 0.005 DBMET00326 0.257 0.007 DBMET00560 | ||
| 0.493 | 0.011 | 0.593 | Psychostimulant | 0.287 0.046 DBMET00271 0.32 0.038 DBMET00272 0.593 0.006 DBMET00535 0.353 0.031 DBMET00326 0.183 0.09 DBMET00560 | DBMET00535 | |
| 0.509 | 0.032 | 0.674 | Aldehyde oxidase inhibitor | 0.602 0.019 DBMET00271 0.674 0.01 DBMET00272 0.249 0.083 DBMET00535 0.314 0.063 DBMET00326 0.525 0.029 DBMET00560 | DBMET00272 | |
| 0.467 | 0.003 | 0.482 | Phosphodiesterase I inhibitor | 0.362 0.004 DBMET00271 0.387 0.004 DBMET00272 0.482 0.003 DBMET00535 0.468 0.003 DBMET00326 0.336 0.004 DBMET00560 | DBMET00535 | |
| 0.457 | 0.003 | 0.457 | Adenosine A3 receptor antagonist | 0.456 0.003 DBMET00271 0.393 0.004 DBMET00272 0.274 0.006 DBMET00535 0.322 0.005 DBMET00326 0.294 0.005 DBMET00560 | ||
| 0.477 | 0.032 | 0.477 | GABA C receptor rho-3 antagonist | 0.477 0.032 DBMET00271 0.477 0.032 DBMET00272 0.463 0.037 DBMET00535 0.441 0.045 DBMET00326 0.474 0.033 DBMET00560 | ||
| 0.451 | 0.016 | 0.647 | Vasodilator | 0.508 0.011 DBMET00271 0.387 0.025 DBMET00272 0.608 0.005 DBMET00535 0.647 0.005 DBMET00326 0.57 0.007 DBMET00560 | DBMET00326 | |
| 0.451 | 0.023 | 0.581 | Vasodilator, coronary | 0.333 0.064 DBMET00271 0.307 0.082 DBMET00272 0.581 0.009 DBMET00535 0.397 0.036 DBMET00326 0.342 0.059 DBMET00560 | DBMET00535 | |
| 0.42 | 0.006 | 0.698 | Phosphodiesterase inhibitor | 0.529 0.005 DBMET00271 0.364 0.009 DBMET00272 0.446 0.005 DBMET00535 0.698 0.004 DBMET00326 0.571 0.005 DBMET00560 | DBMET00326 | |
| 0.415 | 0.007 | 0.415 | Adenylate cyclase inhibitor | 0.343 0.01 DBMET00271 0.36 0.009 DBMET00272 0.303 0.013 DBMET00535 0.369 0.009 DBMET00326 0.264 0.018 DBMET00560 | ||
| 0.421 | 0.025 | 0.664 | Cardiotonic | 0.465 0.019 DBMET00271 0.253 0.08 DBMET00272 0.421 0.025 DBMET00535 0.664 0.005 DBMET00326 0.47 0.019 DBMET00560 | DBMET00326 | |
| 0.399 | 0.004 | 0.489 | Phosphodiesterase 5A inhibitor | 0.278 0.005 DBMET00271 0.27 0.005 DBMET00272 0.413 0.004 DBMET00535 0.489 0.004 DBMET00326 0.263 0.005 DBMET00560 | DBMET00326 | |
| 0.388 | 0.004 | 0.476 | Phosphodiesterase V inhibitor | 0.282 0.005 DBMET00271 0.267 0.005 DBMET00272 0.396 0.004 DBMET00535 0.476 0.004 DBMET00326 0.26 0.005 DBMET00560 | DBMET00326 | |
| 0.399 | 0.018 | 0.511 | RNA-directed DNA polymerase inhibitor | 0.399 0.018 DBMET00271 0.511 0.01 DBMET00272 0.396 0.018 DBMET00535 0.311 0.029 DBMET00326 0.411 0.017 DBMET00560 | DBMET00272 | |
| 0.382 | 0.019 | 0.498 | EphB2 antagonist | 0.405 0.016 DBMET00271 0.498 0.007 DBMET00272 0.233 0.066 DBMET00535 | DBMET00272 | |
| 0.364 | 0.004 | 0.638 | TRPA1 antagonist | 0.112 0.015 DBMET00271 0.094 0.019 DBMET00272 0.638 0.002 DBMET00535 0.286 0.004 DBMET00326 0.163 0.008 DBMET00560 | DBMET00535 | |
| 0.431 | 0.075 | 0.431 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.431 0.075 DBMET00271 0.431 0.075 DBMET00272 0.412 0.09 DBMET00535 0.38 0.119 DBMET00326 0.407 0.095 DBMET00560 | ||
| 0.324 | 0.004 | 0.775 | Phosphodiesterase III inhibitor | 0.554 0.003 DBMET00271 0.29 0.004 DBMET00272 0.258 0.005 DBMET00535 0.775 0.002 DBMET00326 0.708 0.002 DBMET00560 | DBMET00326 | |
| 0.322 | 0.003 | 0.379 | Phosphodiesterase 1B inhibitor | 0.183 0.005 DBMET00271 0.255 0.004 DBMET00272 0.344 0.003 DBMET00535 0.379 0.003 DBMET00326 0.246 0.004 DBMET00560 | DBMET00326 | |
| 0.33 | 0.016 | 0.401 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.292 0.026 DBMET00271 0.327 0.017 DBMET00272 0.401 0.008 DBMET00535 0.212 0.063 DBMET00326 0.23 0.052 DBMET00560 | DBMET00535 | |
| 0.323 | 0.01 | 0.422 | DNA polymerase I inhibitor | 0.294 0.012 DBMET00271 0.422 0.005 DBMET00272 0.099 0.088 DBMET00535 0.179 0.035 DBMET00326 0.102 0.084 DBMET00560 | DBMET00272 | |
| 0.317 | 0.004 | 0.506 | Electrolyte absorption antagonist | 0.167 0.014 DBMET00271 0.164 0.015 DBMET00272 0.506 0.002 DBMET00535 0.215 0.006 DBMET00326 0.158 0.017 DBMET00560 | DBMET00535 | |
| 0.303 | 0.004 | 0.303 | Phosphodiesterase 4C inhibitor | 0.174 0.005 DBMET00271 0.214 0.005 DBMET00272 0.292 0.004 DBMET00535 0.227 0.005 DBMET00326 0.074 0.024 DBMET00560 | ||
| 0.344 | 0.054 | 0.552 | Spasmolytic | 0.212 0.11 DBMET00271 0.191 0.127 DBMET00272 0.552 0.018 DBMET00535 0.478 0.026 DBMET00326 0.28 0.078 DBMET00560 | DBMET00535 | |
| 0.279 | 0.005 | 0.31 | Phosphodiesterase 7B inhibitor | 0.247 0.006 DBMET00271 0.262 0.005 DBMET00272 0.196 0.011 DBMET00535 0.308 0.004 DBMET00326 0.31 0.004 DBMET00560 | DBMET00560 | |
| 0.271 | 0.005 | 0.396 | DNA repair enzyme inhibitor | 0.235 0.006 DBMET00271 0.246 0.005 DBMET00272 0.396 0.003 DBMET00535 0.253 0.005 DBMET00326 0.206 0.008 DBMET00560 | DBMET00535 | |
| 0.264 | 0.006 | 0.281 | Phosphodiesterase 4D inhibitor | 0.116 0.03 DBMET00271 0.185 0.013 DBMET00272 0.281 0.005 DBMET00535 0.258 0.007 DBMET00326 0.094 0.039 DBMET00560 | DBMET00535 | |
| 0.248 | 0.003 | 0.347 | Phosphodiesterase 1A inhibitor | 0.162 0.004 DBMET00271 0.196 0.004 DBMET00272 0.259 0.003 DBMET00535 0.347 0.002 DBMET00326 0.243 0.003 DBMET00560 | DBMET00326 | |
| 0.29 | 0.047 | 0.406 | DNA synthesis inhibitor | 0.323 0.037 DBMET00271 0.406 0.021 DBMET00272 0.262 0.059 DBMET00535 0.207 0.113 DBMET00326 0.302 0.043 DBMET00560 | DBMET00272 | |
| 0.234 | 0.004 | 0.234 | Phosphodiesterase VI inhibitor | 0.134 0.009 DBMET00271 0.161 0.005 DBMET00272 0.201 0.004 DBMET00535 0.173 0.005 DBMET00326 0.113 0.014 DBMET00560 | ||
| 0.233 | 0.004 | 0.276 | Nicotinic acid receptor 1 agonist | 0.182 0.004 DBMET00271 0.202 0.004 DBMET00272 0.134 0.005 DBMET00535 0.276 0.003 DBMET00326 0.235 0.004 DBMET00560 | DBMET00326 | |
| 0.335 | 0.107 | 0.515 | Histamine release inhibitor | 0.413 0.069 DBMET00271 0.348 0.101 DBMET00272 0.28 0.135 DBMET00535 0.436 0.057 DBMET00326 0.515 0.024 DBMET00560 | DBMET00560 | |
| 0.251 | 0.03 | 0.339 | Tumour necrosis factor antagonist | 0.166 0.081 DBMET00271 0.287 0.021 DBMET00272 0.339 0.012 DBMET00535 0.227 0.039 DBMET00326 0.219 0.043 DBMET00560 | DBMET00535 | |
| 0.352 | 0.137 | 0.459 | DNA directed DNA polymerase inhibitor | 0.297 0.163 DBMET00271 0.459 0.095 DBMET00272 0.419 0.108 DBMET00535 0.364 0.132 DBMET00326 0.283 0.171 DBMET00560 | DBMET00272 | |
| 0.213 | 0.009 | 0.345 | NADH dehydrogenase inhibitor | 0.216 0.009 DBMET00271 0.345 0.005 DBMET00272 0.182 0.012 DBMET00535 0.106 0.038 DBMET00326 0.116 0.031 DBMET00560 | DBMET00272 | |
| 0.253 | 0.052 | 0.326 | MAP kinase kinase 2 inhibitor | 0.326 0.027 DBMET00271 0.201 0.081 DBMET00272 0.304 0.034 DBMET00535 0.203 0.08 DBMET00326 0.255 0.051 DBMET00560 | DBMET00271 | |
| 0.293 | 0.096 | 0.476 | Cholesterol antagonist | 0.476 0.036 DBMET00535 0.228 0.141 DBMET00326 0.191 0.173 DBMET00560 | DBMET00535 | |
| 0.198 | 0.005 | 0.221 | Phosphodiesterase 6D inhibitor | 0.138 0.013 DBMET00271 0.162 0.007 DBMET00272 0.192 0.005 DBMET00535 0.221 0.004 DBMET00326 0.159 0.008 DBMET00560 | DBMET00326 | |
| 0.337 | 0.145 | 0.47 | MAP kinase 1 inhibitor | 0.309 0.171 DBMET00271 0.309 0.17 DBMET00272 0.47 0.067 DBMET00535 0.444 0.081 DBMET00326 0.296 0.185 DBMET00560 | DBMET00535 | |
| 0.227 | 0.039 | 0.292 | Histone acetyltransferase inhibitor | 0.191 0.083 DBMET00271 0.199 0.071 DBMET00272 0.292 0.015 DBMET00535 0.202 0.066 DBMET00326 0.155 0.133 DBMET00560 | DBMET00535 | |
| 0.193 | 0.009 | 0.238 | Phosphodiesterase 3A inhibitor | 0.156 0.015 DBMET00271 0.169 0.012 DBMET00272 0.17 0.012 DBMET00535 0.238 0.005 DBMET00326 0.117 0.023 DBMET00560 | DBMET00326 | |
| 0.185 | 0.005 | 0.203 | Cyclin B1 inhibitor | 0.188 0.005 DBMET00271 0.203 0.004 DBMET00272 | DBMET00272 | |
| 0.187 | 0.009 | 0.211 | Heat shock protein 70 antagonist | 0.167 0.02 DBMET00271 0.166 0.021 DBMET00272 0.211 0.005 DBMET00535 0.161 0.026 DBMET00326 0.163 0.024 DBMET00560 | DBMET00535 | |
| 0.183 | 0.008 | 0.185 | Phosphodiesterase 4A inhibitor | 0.085 0.019 DBMET00271 0.113 0.013 DBMET00272 0.185 0.008 DBMET00535 0.108 0.014 DBMET00326 | DBMET00535 | |
| 0.173 | 0.004 | 0.268 | Phosphodiesterase 1C inhibitor | 0.097 0.011 DBMET00271 0.122 0.006 DBMET00272 0.199 0.004 DBMET00535 0.268 0.003 DBMET00326 0.163 0.004 DBMET00560 | DBMET00326 | |
| 0.169 | 0.005 | 0.182 | Cyclin B inhibitor | 0.163 0.005 DBMET00271 0.182 0.005 DBMET00272 | DBMET00272 | |
| 0.164 | 0.002 | 0.505 | Phosphodiesterase 6B inhibitor | 0.12 0.003 DBMET00271 0.097 0.003 DBMET00272 0.128 0.002 DBMET00535 0.505 0.001 DBMET00326 0.128 0.002 DBMET00560 | DBMET00326 | |
| 0.21 | 0.048 | 0.21 | 5 Hydroxytryptamine 3E antagonist | 0.21 0.048 DBMET00271 0.21 0.048 DBMET00272 0.168 0.141 DBMET00535 0.169 0.141 DBMET00560 | ||
| 0.164 | 0.005 | 0.177 | Cyclin B2 inhibitor | 0.167 0.005 DBMET00271 0.177 0.004 DBMET00272 | DBMET00272 | |
| 0.192 | 0.033 | 0.264 | Cell wall synthesis inhibitor | 0.153 0.063 DBMET00271 0.193 0.033 DBMET00272 0.264 0.014 DBMET00535 0.121 0.097 DBMET00560 | DBMET00535 | |
| 0.169 | 0.012 | 0.176 | Protein kinase B gamma inhibitor | 0.176 0.01 DBMET00271 0.153 0.015 DBMET00535 0.133 0.021 DBMET00326 0.149 0.016 DBMET00560 | DBMET00271 | |
| 0.156 | 0.002 | 0.768 | Phosphodiesterase 6A inhibitor | 0.092 0.003 DBMET00271 0.059 0.004 DBMET00272 0.103 0.003 DBMET00535 0.768 0.001 DBMET00326 0.127 0.002 DBMET00560 | DBMET00326 | |
| 0.183 | 0.034 | 0.183 | CF transmembrane conductance regulator agonist | 0.159 0.061 DBMET00271 0.139 0.097 DBMET00272 0.173 0.043 DBMET00535 0.13 0.119 DBMET00326 | ||
| 0.19 | 0.041 | 0.347 | Ribosomal protein S6 kinase inhibitor | 0.193 0.04 DBMET00271 0.347 0.007 DBMET00272 0.119 0.091 DBMET00535 | DBMET00272 | |
| 0.154 | 0.012 | 0.169 | Phosphodiesterase 4B inhibitor | 0.07 0.044 DBMET00271 0.103 0.024 DBMET00272 0.169 0.01 DBMET00535 0.078 0.037 DBMET00326 | DBMET00535 | |
| 0.141 | 0.004 | 0.192 | Thymidine kinase inhibitor | 0.139 0.004 DBMET00271 0.192 0.003 DBMET00272 0.115 0.005 DBMET00535 0.085 0.008 DBMET00326 0.079 0.009 DBMET00560 | DBMET00272 | |
| 0.193 | 0.061 | 0.241 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET00271 0.192 0.061 DBMET00535 0.241 0.037 DBMET00326 0.197 0.058 DBMET00560 | DBMET00326 | |
| 0.16 | 0.034 | 0.248 | Ferrochelatase inhibitor | 0.16 0.034 DBMET00271 0.16 0.034 DBMET00272 0.146 0.039 DBMET00535 0.217 0.019 DBMET00326 0.248 0.013 DBMET00560 | DBMET00560 | |
| 0.125 | 0.002 | 0.438 | Phosphodiesterase 6C inhibitor | 0.091 0.003 DBMET00271 0.079 0.004 DBMET00272 0.106 0.003 DBMET00535 0.438 0.001 DBMET00326 0.111 0.003 DBMET00560 | DBMET00326 | |
| 0.157 | 0.038 | 0.202 | Cyclin-dependent kinase 1 inhibitor | 0.202 0.026 DBMET00271 0.188 0.029 DBMET00272 | DBMET00271 | |
| 0.151 | 0.033 | 0.151 | GABA C receptor agonist | 0.151 0.033 DBMET00271 0.151 0.033 DBMET00272 0.102 0.064 DBMET00535 0.103 0.063 DBMET00326 0.118 0.051 DBMET00560 | ||
| 0.173 | 0.056 | 0.236 | Acetylcholine M1 receptor antagonist | 0.133 0.092 DBMET00272 0.236 0.029 DBMET00535 0.178 0.053 DBMET00326 0.162 0.064 DBMET00560 | DBMET00535 | |
| 0.153 | 0.038 | 0.155 | Sphingosine 1-phosphate receptor 2 antagonist | 0.155 0.035 DBMET00535 0.142 0.052 DBMET00326 0.121 0.093 DBMET00560 | DBMET00535 | |
| 0.13 | 0.017 | 0.13 | Alpha 2d adrenoreceptor antagonist | 0.13 0.017 DBMET00271 0.13 0.017 DBMET00272 | ||
| 0.123 | 0.013 | 0.201 | Biliverdin reductase inhibitor | 0.095 0.02 DBMET00271 0.201 0.005 DBMET00272 0.127 0.012 DBMET00535 0.068 0.033 DBMET00326 0.079 0.026 DBMET00560 | DBMET00272 | |
| 0.121 | 0.015 | 0.147 | Carbamoyl phosphate synthetase inhibitor | 0.121 0.015 DBMET00271 0.147 0.011 DBMET00272 0.113 0.017 DBMET00535 0.073 0.033 DBMET00326 0.082 0.028 DBMET00560 | DBMET00272 | |
| 0.133 | 0.028 | 0.238 | Phosphodiesterase IV inhibitor | 0.149 0.023 DBMET00271 0.102 0.043 DBMET00272 0.128 0.03 DBMET00535 0.238 0.009 DBMET00326 0.134 0.027 DBMET00560 | DBMET00326 | |
| 0.161 | 0.06 | 0.191 | GABA C receptor rho-2 antagonist | 0.161 0.06 DBMET00271 0.191 0.034 DBMET00272 0.145 0.08 DBMET00535 0.154 0.068 DBMET00326 0.169 0.052 DBMET00560 | DBMET00272 | |
| 0.109 | 0.009 | 0.255 | Phosphodiesterase VII inhibitor | 0.099 0.013 DBMET00271 0.099 0.013 DBMET00272 0.108 0.009 DBMET00535 0.255 0.004 DBMET00326 0.209 0.004 DBMET00560 | DBMET00326 | |
| 0.157 | 0.058 | 0.179 | MAP kinase 3 inhibitor | 0.179 0.035 DBMET00271 0.168 0.045 DBMET00272 0.126 0.117 DBMET00535 | DBMET00271 | |
| 0.106 | 0.01 | 0.223 | Phosphodiesterase II inhibitor | 0.078 0.019 DBMET00271 0.116 0.008 DBMET00272 0.223 0.004 DBMET00535 0.084 0.016 DBMET00326 | DBMET00535 | |
| 0.136 | 0.041 | 0.199 | Mucolytic | 0.094 0.087 DBMET00272 0.199 0.013 DBMET00535 0.124 0.05 DBMET00326 0.102 0.075 DBMET00560 | DBMET00535 | |
| 0.144 | 0.052 | 0.173 | Nav1.3 sodium channel blocker | 0.141 0.054 DBMET00271 0.134 0.06 DBMET00272 0.173 0.035 DBMET00326 0.16 0.042 DBMET00560 | DBMET00326 | |
| 0.103 | 0.01 | 0.283 | Phosphodiesterase 3B inhibitor | 0.191 0.005 DBMET00271 0.086 0.014 DBMET00272 0.1 0.011 DBMET00535 0.283 0.004 DBMET00326 0.149 0.005 DBMET00560 | DBMET00326 | |
| 0.095 | 0.006 | 0.105 | Adenosine deaminase inhibitor | 0.086 0.008 DBMET00271 0.097 0.006 DBMET00272 0.105 0.005 DBMET00535 0.063 0.018 DBMET00326 0.051 0.03 DBMET00560 | DBMET00535 | |
| 0.242 | 0.155 | 0.325 | Calpain 2 inhibitor | 0.325 0.099 DBMET00535 | DBMET00535 | |
| 0.125 | 0.039 | 0.134 | Adenylate kinase inhibitor | 0.125 0.039 DBMET00271 0.125 0.039 DBMET00272 0.134 0.033 DBMET00535 0.096 0.074 DBMET00326 0.105 0.06 DBMET00560 | DBMET00535 | |
| 0.12 | 0.035 | 0.166 | MAP kinase kinase 1 inhibitor | 0.166 0.011 DBMET00271 0.143 0.019 DBMET00272 0.125 0.03 DBMET00535 0.112 0.043 DBMET00560 | DBMET00271 | |
| 0.093 | 0.009 | 0.096 | Corticotropin releasing factor 2 receptor antagonist | 0.079 0.018 DBMET00271 0.078 0.019 DBMET00272 0.096 0.008 DBMET00535 0.068 0.032 DBMET00326 0.062 0.041 DBMET00560 | DBMET00535 | |
| 0.107 | 0.028 | 0.165 | Myeloperoxidase inhibitor | 0.093 0.044 DBMET00271 0.165 0.009 DBMET00272 | DBMET00272 | |
| 0.147 | 0.067 | 0.147 | Sphingosine 1-phosphate receptor 5 antagonist | 0.146 0.068 DBMET00535 0.133 0.093 DBMET00326 | ||
| 0.13 | 0.051 | 0.199 | Cystathionine beta-synthase inhibitor | 0.13 0.051 DBMET00271 0.162 0.036 DBMET00535 0.176 0.031 DBMET00326 0.199 0.025 DBMET00560 | DBMET00560 | |
| 0.123 | 0.046 | 0.17 | Xanthine oxidase inhibitor | 0.17 0.027 DBMET00271 0.153 0.033 DBMET00272 0.134 0.041 DBMET00535 0.09 0.071 DBMET00326 0.124 0.045 DBMET00560 | DBMET00271 | |
| 0.088 | 0.011 | 0.212 | Phosphodiesterase 2A inhibitor | 0.063 0.022 DBMET00271 0.098 0.009 DBMET00272 0.212 0.004 DBMET00535 0.076 0.015 DBMET00326 | DBMET00535 | |
| 0.128 | 0.052 | 0.206 | Interleukin 8 antagonist | 0.206 0.011 DBMET00272 0.192 0.015 DBMET00535 | DBMET00272 | |
| 0.09 | 0.015 | 0.131 | Bromodomain-containing protein 4 inhibitor | 0.095 0.014 DBMET00271 0.084 0.017 DBMET00272 0.131 0.008 DBMET00535 0.08 0.019 DBMET00326 0.118 0.01 DBMET00560 | DBMET00535 | |
| 0.077 | 0.002 | 0.468 | Phosphodiesterase 6G inhibitor | 0.055 0.003 DBMET00271 0.044 0.004 DBMET00272 0.066 0.002 DBMET00535 0.468 0.001 DBMET00326 0.071 0.002 DBMET00560 | DBMET00326 | |
| 0.077 | 0.002 | 0.468 | Phosphodiesterase 6H inhibitor | 0.055 0.003 DBMET00271 0.044 0.004 DBMET00272 0.066 0.002 DBMET00535 0.468 0.001 DBMET00326 0.071 0.002 DBMET00560 | DBMET00326 | |
| 0.256 | 0.182 | 0.274 | MAP kinase kinase 6 inhibitor | 0.232 0.215 DBMET00271 0.256 0.182 DBMET00272 0.274 0.162 DBMET00535 | DBMET00535 | |
| 0.078 | 0.004 | 0.096 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.087 0.004 DBMET00271 0.096 0.003 DBMET00272 0.053 0.008 DBMET00535 0.045 0.01 DBMET00326 0.061 0.007 DBMET00560 | DBMET00272 | |
| 0.091 | 0.018 | 0.131 | Antimetabolite | 0.118 0.014 DBMET00271 0.131 0.013 DBMET00272 0.052 0.03 DBMET00535 0.055 0.029 DBMET00326 0.059 0.026 DBMET00560 | DBMET00272 | |
| 0.084 | 0.012 | 0.142 | Dipeptidyl peptidase inhibitor | 0.05 0.042 DBMET00272 0.142 0.005 DBMET00535 0.062 0.024 DBMET00326 | DBMET00535 | |
| 0.116 | 0.045 | 0.116 | Antihistaminic | 0.083 0.073 DBMET00272 | ||
| 0.216 | 0.145 | 0.54 | Immunomodulator | 0.212 0.15 DBMET00271 0.262 0.105 DBMET00272 0.54 0.018 DBMET00535 0.25 0.115 DBMET00326 | DBMET00535 | |
| 0.077 | 0.007 | 0.077 | Histamine H3 receptor agonist | 0.077 0.007 DBMET00271 0.075 0.008 DBMET00272 | ||
| 0.077 | 0.008 | 0.148 | Dipeptidyl peptidase IV inhibitor | 0.043 0.034 DBMET00271 0.045 0.028 DBMET00272 0.148 0.004 DBMET00535 0.054 0.017 DBMET00326 0.042 0.036 DBMET00560 | DBMET00535 | |
| 0.147 | 0.078 | 0.197 | Cytidine deaminase inhibitor | 0.159 0.069 DBMET00271 0.197 0.049 DBMET00272 0.146 0.078 DBMET00535 0.13 0.091 DBMET00560 | DBMET00272 | |
| 0.181 | 0.114 | 0.181 | ErbB-1 antagonist | 0.181 0.114 DBMET00271 0.181 0.114 DBMET00272 0.164 0.145 DBMET00535 | ||
| 0.072 | 0.008 | 0.109 | Nicotinic acid receptor agonist | 0.041 0.02 DBMET00271 0.07 0.009 DBMET00272 0.045 0.017 DBMET00535 0.109 0.004 DBMET00326 0.088 0.005 DBMET00560 | DBMET00326 | |
| 0.087 | 0.025 | 0.087 | 5 Hydroxytryptamine 3A antagonist | 0.086 0.025 DBMET00271 0.08 0.031 DBMET00272 0.075 0.036 DBMET00535 0.071 0.041 DBMET00326 0.082 0.029 DBMET00560 | ||
| 0.082 | 0.019 | 0.126 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.082 0.019 DBMET00271 0.126 0.01 DBMET00272 0.089 0.017 DBMET00535 0.057 0.038 DBMET00326 0.064 0.031 DBMET00560 | DBMET00272 | |
| 0.11 | 0.049 | 0.136 | GABA C receptor rho-1 antagonist | 0.11 0.049 DBMET00271 0.136 0.028 DBMET00272 0.096 0.068 DBMET00560 | DBMET00272 | |
| 0.067 | 0.007 | 0.112 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 DBMET00271 0.049 0.011 DBMET00272 0.112 0.004 DBMET00535 | DBMET00535 | |
| 0.127 | 0.067 | 0.19 | MAP kinase kinase inhibitor | 0.19 0.032 DBMET00271 0.185 0.034 DBMET00272 0.16 0.046 DBMET00535 0.102 0.092 DBMET00560 | DBMET00271 | |
| 0.06 | 0.004 | 0.102 | Adenosine uptake inhibitor | 0.039 0.013 DBMET00271 0.045 0.007 DBMET00272 0.102 0.002 DBMET00535 0.043 0.008 DBMET00326 0.035 0.022 DBMET00560 | DBMET00535 | |
| 0.108 | 0.053 | 0.134 | UDP-glucose 4-epimerase inhibitor | 0.108 0.053 DBMET00271 0.134 0.035 DBMET00272 0.11 0.051 DBMET00535 0.115 0.046 DBMET00326 0.129 0.038 DBMET00560 | DBMET00272 | |
| 0.126 | 0.073 | 0.156 | Antibacterial (Helicobacter pylori) | 0.156 0.042 DBMET00535 | DBMET00535 | |
| 0.1 | 0.048 | 0.1 | Histamine antagonist | |||
| 0.091 | 0.039 | 0.113 | Caspase 7 inhibitor | 0.113 0.018 DBMET00535 0.104 0.025 DBMET00326 0.081 0.058 DBMET00560 | DBMET00535 | |
| 0.074 | 0.025 | 0.074 | Heat shock protein 90 beta antagonist | 0.058 0.044 DBMET00271 0.06 0.039 DBMET00535 | ||
| 0.09 | 0.042 | 0.174 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.174 0.008 DBMET00271 0.109 0.031 DBMET00272 0.075 0.059 DBMET00560 | DBMET00271 | |
| 0.083 | 0.036 | 0.083 | MAP kinase 7 inhibitor | 0.083 0.036 DBMET00272 0.083 0.033 DBMET00535 | ||
| 0.121 | 0.074 | 0.161 | MAO inhibitor | 0.161 0.055 DBMET00535 0.104 0.086 DBMET00326 | DBMET00535 | |
| 0.086 | 0.042 | 0.16 | Alpha 1b adrenoreceptor antagonist | 0.129 0.027 DBMET00271 0.065 0.056 DBMET00535 0.133 0.026 DBMET00326 0.16 0.02 DBMET00560 | DBMET00560 | |
| 0.073 | 0.029 | 0.128 | Argininosuccinate synthase inhibitor | 0.073 0.029 DBMET00271 0.128 0.014 DBMET00272 0.055 0.041 DBMET00535 | DBMET00272 | |
| 0.056 | 0.013 | 0.056 | Alpha 1d adrenoreceptor agonist | 0.056 0.013 DBMET00271 0.056 0.013 DBMET00272 | ||
| 0.144 | 0.101 | 0.23 | Antipruritic | 0.23 0.032 DBMET00535 | DBMET00535 | |
| 0.105 | 0.063 | 0.183 | Expectorant | 0.183 0.024 DBMET00535 0.103 0.065 DBMET00326 0.091 0.08 DBMET00560 | DBMET00535 | |
| 0.084 | 0.041 | 0.103 | Glutamate dehydrogenase inhibitor | 0.084 0.041 DBMET00271 0.103 0.029 DBMET00272 0.077 0.048 DBMET00535 | DBMET00272 | |
| 0.061 | 0.019 | 0.061 | Alpha 1b adrenoreceptor agonist | 0.061 0.019 DBMET00271 0.061 0.019 DBMET00272 | ||
| 0.08 | 0.038 | 0.101 | Alpha adrenoreceptor agonist | 0.101 0.028 DBMET00271 0.068 0.047 DBMET00272 | DBMET00271 | |
| 0.064 | 0.024 | 0.064 | Histamine agonist | 0.064 0.024 DBMET00271 0.064 0.024 DBMET00272 | ||
| 0.097 | 0.058 | 0.153 | Alpha adrenoreceptor antagonist | 0.153 0.037 DBMET00271 0.091 0.062 DBMET00326 0.112 0.05 DBMET00560 | DBMET00271 | |
| 0.098 | 0.06 | 0.136 | MAO B inhibitor | 0.136 0.043 DBMET00535 0.091 0.065 DBMET00326 | DBMET00535 | |
| 0.043 | 0.006 | 0.088 | Thymidine phosphorylase inhibitor | 0.064 0.004 DBMET00271 0.055 0.004 DBMET00272 0.037 0.007 DBMET00535 0.067 0.004 DBMET00326 0.088 0.003 DBMET00560 | DBMET00560 | |
| 0.041 | 0.005 | 0.069 | DNA polymerase III inhibitor | 0.054 0.003 DBMET00271 0.069 0.003 DBMET00272 0.048 0.004 DBMET00535 0.033 0.01 DBMET00326 0.053 0.003 DBMET00560 | DBMET00272 | |
| 0.115 | 0.079 | 0.172 | c-Src kinase inhibitor | 0.172 0.045 DBMET00271 0.146 0.058 DBMET00272 | DBMET00271 | |
| 0.049 | 0.014 | 0.049 | Glucagon-like peptide 1 receptor antagonist | 0.043 0.021 DBMET00535 0.043 0.021 DBMET00326 | ||
| 0.051 | 0.017 | 0.055 | Angiotensin AT1 receptor antagonist | 0.055 0.011 DBMET00535 | DBMET00535 | |
| 0.049 | 0.016 | 0.049 | Vascular adhesion protein 1 inhibitor | 0.04 0.025 DBMET00271 | ||
| 0.05 | 0.018 | 0.05 | Histamine H1 receptor agonist | 0.05 0.018 DBMET00271 0.05 0.018 DBMET00272 | ||
| 0.083 | 0.051 | 0.138 | Alpha 1 adrenoreceptor antagonist | 0.138 0.032 DBMET00271 0.094 0.046 DBMET00326 0.115 0.038 DBMET00560 | DBMET00271 | |
| 0.043 | 0.011 | 0.063 | Purinergic P2X agonist | 0.027 0.019 DBMET00271 0.027 0.019 DBMET00272 0.063 0.006 DBMET00535 0.03 0.018 DBMET00326 | DBMET00535 | |
| 0.07 | 0.038 | 0.077 | Cyclin A2 inhibitor | 0.067 0.041 DBMET00271 0.077 0.034 DBMET00272 | DBMET00272 | |
| 0.174 | 0.142 | 0.234 | MAP-kinase-activated kinase 5 inhibitor | 0.174 0.142 DBMET00271 0.234 0.07 DBMET00272 | DBMET00272 | |
| 0.064 | 0.032 | 0.064 | 5 Hydroxytryptamine 3 antagonist | 0.063 0.033 DBMET00271 0.059 0.037 DBMET00272 | ||
| 0.034 | 0.003 | 0.043 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.043 0.002 DBMET00271 0.035 0.003 DBMET00272 0.018 0.01 DBMET00326 0.019 0.008 DBMET00560 | DBMET00271 | |
| 0.143 | 0.113 | 0.143 | Cyclin-dependent kinase 3 inhibitor | 0.143 0.113 DBMET00272 | ||
| 0.037 | 0.006 | 0.072 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.043 0.004 DBMET00271 0.072 0.003 DBMET00272 0.03 0.011 DBMET00535 0.027 0.017 DBMET00560 | DBMET00272 | |
| 0.051 | 0.022 | 0.074 | AICAR transformylase inhibitor | 0.074 0.009 DBMET00271 0.07 0.01 DBMET00272 0.04 0.039 DBMET00326 0.044 0.03 DBMET00560 | DBMET00271 | |
| 0.11 | 0.081 | 0.149 | Transcription factor STAT6 inhibitor | 0.149 0.024 DBMET00535 | DBMET00535 | |
| 0.032 | 0.004 | 0.048 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.032 0.004 DBMET00271 0.048 0.003 DBMET00272 0.024 0.008 DBMET00535 | DBMET00272 | |
| 0.102 | 0.075 | 0.144 | Polo-like kinase-4 inhibitor | 0.144 0.04 DBMET00271 0.113 0.063 DBMET00272 | DBMET00271 | |
| 0.06 | 0.033 | 0.075 | Acyl-CoA dehydrogenase inhibitor | 0.06 0.033 DBMET00271 0.06 0.033 DBMET00272 0.075 0.024 DBMET00535 | DBMET00535 | |
| 0.048 | 0.022 | 0.103 | Glutamate (mGluR4) antagonist | 0.058 0.015 DBMET00271 0.103 0.005 DBMET00272 0.046 0.026 DBMET00560 | DBMET00272 | |
| 0.089 | 0.063 | 0.125 | Polo-like kinase-1 inhibitor | 0.109 0.037 DBMET00271 0.125 0.028 DBMET00272 0.106 0.039 DBMET00535 0.104 0.041 DBMET00560 | DBMET00272 | |
| 0.078 | 0.053 | 0.078 | MAP kinase kinase 7 inhibitor | 0.078 0.053 DBMET00271 0.078 0.053 DBMET00272 | ||
| 0.058 | 0.034 | 0.09 | GABA receptor antagonist | 0.052 0.042 DBMET00272 0.09 0.018 DBMET00535 | DBMET00535 | |
| 0.055 | 0.03 | 0.114 | Phosphodiesterase 7A inhibitor | 0.07 0.011 DBMET00535 0.114 0.004 DBMET00326 0.109 0.004 DBMET00560 | DBMET00326 | |
| 0.085 | 0.061 | 0.085 | Histamine N-methyltransferase inhibitor | 0.085 0.061 DBMET00271 0.085 0.061 DBMET00272 | ||
| 0.172 | 0.148 | 0.197 | Nitric-oxide synthase stimulant | 0.197 0.094 DBMET00271 0.197 0.093 DBMET00272 0.173 0.144 DBMET00326 0.186 0.114 DBMET00560 | DBMET00272 | |
| 0.061 | 0.038 | 0.061 | Cyclin H inhibitor | 0.061 0.038 DBMET00272 | ||
| 0.051 | 0.029 | 0.051 | Histamine H4 receptor antagonist | 0.051 0.029 DBMET00271 0.051 0.029 DBMET00272 | ||
| 0.029 | 0.009 | 0.029 | Alpha 2d adrenoreceptor agonist | 0.029 0.009 DBMET00271 0.029 0.009 DBMET00272 | ||
| 0.042 | 0.022 | 0.054 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET00271 0.054 0.005 DBMET00535 0.04 0.026 DBMET00326 0.038 0.036 DBMET00560 | DBMET00535 | |
| 0.058 | 0.039 | 0.078 | Alpha 1 adrenoreceptor agonist | 0.078 0.024 DBMET00271 0.051 0.048 DBMET00272 0.052 0.048 DBMET00560 | DBMET00271 | |
| 0.078 | 0.059 | 0.096 | Histamine H1 receptor antagonist | 0.096 0.043 DBMET00535 | DBMET00535 | |
| 0.037 | 0.019 | 0.041 | Angiotensin II receptor antagonist | 0.041 0.013 DBMET00535 | DBMET00535 | |
| 0.061 | 0.043 | 0.068 | Cyclin A inhibitor | 0.057 0.046 DBMET00271 0.068 0.039 DBMET00272 | DBMET00272 | |
| 0.187 | 0.169 | 0.221 | Gastrin inhibitor | 0.221 0.118 DBMET00272 0.181 0.178 DBMET00560 | DBMET00272 | |
| 0.069 | 0.052 | 0.085 | Benzodiazepine agonist | 0.085 0.035 DBMET00271 0.069 0.053 DBMET00535 0.077 0.042 DBMET00326 0.085 0.035 DBMET00560 | DBMET00560 | |
| 0.045 | 0.028 | 0.079 | Glutamate (mGluR group III) antagonist | 0.051 0.02 DBMET00271 0.079 0.008 DBMET00272 0.047 0.025 DBMET00560 | DBMET00272 | |
| 0.098 | 0.081 | 0.122 | GABA C receptor antagonist | 0.098 0.081 DBMET00271 0.122 0.051 DBMET00272 | DBMET00272 | |
| 0.039 | 0.022 | 0.039 | 5 Hydroxytryptamine 3B antagonist | 0.038 0.023 DBMET00271 0.038 0.023 DBMET00272 0.032 0.03 DBMET00560 | ||
| 0.028 | 0.012 | 0.034 | Acid ceramidase inhibitor | 0.028 0.012 DBMET00271 0.034 0.006 DBMET00272 0.031 0.008 DBMET00535 0.03 0.009 DBMET00326 0.034 0.006 DBMET00560 | DBMET00560 | |
| 0.037 | 0.022 | 0.064 | ATM kinase inhibitor | 0.064 0.005 DBMET00535 0.034 0.032 DBMET00326 | DBMET00535 | |
| 0.121 | 0.107 | 0.168 | Src kinase inhibitor | 0.168 0.072 DBMET00271 0.145 0.086 DBMET00272 | DBMET00271 | |
| 0.043 | 0.029 | 0.043 | Histamine H2 receptor agonist | 0.043 0.029 DBMET00271 0.043 0.029 DBMET00272 | ||
| 0.102 | 0.088 | 0.134 | Cyclin-dependent kinase inhibitor | 0.134 0.065 DBMET00271 0.103 0.088 DBMET00272 | DBMET00271 | |
| 0.112 | 0.101 | 0.117 | Histone deacetylase SIRT1 inhibitor | 0.117 0.095 DBMET00271 | DBMET00271 | |
| 0.079 | 0.068 | 0.079 | Transforming growth factor beta 3 antagonist | 0.078 0.07 DBMET00535 | ||
| 0.014 | 0.005 | 0.02 | Purine nucleoside phosphorylase inhibitor | 0.017 0.004 DBMET00271 0.02 0.003 DBMET00272 | DBMET00272 | |
| 0.018 | 0.009 | 0.021 | Adenosine A2 receptor agonist | 0.021 0.007 DBMET00535 | DBMET00535 | |
| 0.035 | 0.026 | 0.074 | Nicotinic acid receptor 2 agonist | 0.042 0.019 DBMET00272 0.066 0.01 DBMET00326 0.074 0.009 DBMET00560 | DBMET00560 | |
| 0.014 | 0.006 | 0.03 | DNA polymerase III polC-type inhibitor | 0.021 0.004 DBMET00271 0.03 0.003 DBMET00272 0.016 0.005 DBMET00535 0.021 0.004 DBMET00560 | DBMET00272 | |
| 0.014 | 0.006 | 0.016 | Egl nine homolog 3 inhibitor | 0.016 0.005 DBMET00271 0.016 0.005 DBMET00272 | DBMET00272 | |
| 0.052 | 0.047 | 0.093 | Alpha 1d adrenoreceptor antagonist | 0.083 0.029 DBMET00271 0.066 0.037 DBMET00326 0.093 0.025 DBMET00560 | DBMET00560 | |
| 0.049 | 0.043 | 0.049 | GABA A receptor antagonist | |||
| 0.027 | 0.022 | 0.029 | Purinergic P2Y15 antagonist | 0.027 0.022 DBMET00271 0.027 0.022 DBMET00272 0.029 0.018 DBMET00535 | DBMET00535 | |
| 0.091 | 0.087 | 0.189 | 5 Hydroxytryptamine 3A agonist | 0.091 0.087 DBMET00271 0.091 0.087 DBMET00272 0.168 0.026 DBMET00326 0.189 0.018 DBMET00560 | DBMET00560 | |
| 0.008 | 0.004 | 0.016 | DNA polymerase III subunit alpha inhibitor | 0.007 0.005 DBMET00271 0.014 0.003 DBMET00272 0.016 0.002 DBMET00535 | DBMET00535 | |
| 0.031 | 0.028 | 0.058 | Protein kinase (CK2) beta inhibitor | 0.035 0.02 DBMET00271 0.046 0.009 DBMET00272 0.041 0.012 DBMET00326 0.058 0.005 DBMET00560 | DBMET00560 | |
| 0.047 | 0.044 | 0.058 | Antiviral (Hepatitis D) | 0.048 0.041 DBMET00271 0.05 0.036 DBMET00272 0.058 0.025 DBMET00535 0.05 0.036 DBMET00560 | DBMET00535 | |
| 0.078 | 0.075 | 0.08 | mTOR complex 2 inhibitor | 0.079 0.072 DBMET00271 0.078 0.075 DBMET00272 0.08 0.068 DBMET00535 | DBMET00535 | |
| 0.129 | 0.127 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.129 0.127 DBMET00271 0.129 0.127 DBMET00272 0.137 0.087 DBMET00535 0.132 0.11 DBMET00326 0.136 0.09 DBMET00560 | DBMET00535 | |
| 0.141 | 0.14 | 0.155 | Anticonvulsant | 0.144 0.137 DBMET00272 0.155 0.123 DBMET00535 0.149 0.13 DBMET00560 | DBMET00535 | |
| 0.045 | 0.046 | 0.074 | mTOR inhibitor | 0.074 0.02 DBMET00271 0.049 0.039 DBMET00272 | DBMET00271 | |
| 0.01 | 0.011 | 0.013 | Egl nine homolog 2 inhibitor | 0.013 0.008 DBMET00271 | DBMET00271 | |
| 0.03 | 0.031 | 0.035 | ATR kinase inhibitor | 0.035 0.018 DBMET00535 | DBMET00535 | |
| 0.057 | 0.059 | 0.094 | Phosphofructokinase-1 inhibitor | 0.094 0.034 DBMET00272 0.073 0.045 DBMET00535 | DBMET00272 | |
| 0.07 | 0.072 | 0.137 | Acetylcholine M3 receptor agonist | 0.121 0.034 DBMET00326 0.137 0.026 DBMET00560 | DBMET00560 | |
| 0.044 | 0.046 | 0.066 | Ornithine carbamoyltransferase inhibitor | 0.066 0.028 DBMET00272 0.046 0.044 DBMET00535 | DBMET00272 | |
| 0.06 | 0.065 | 0.077 | Glutamate (mGluR7) antagonist | 0.072 0.038 DBMET00535 0.07 0.043 DBMET00326 0.077 0.031 DBMET00560 | DBMET00560 | |
| 0.054 | 0.059 | 0.063 | 5 Hydroxytryptamine 3 agonist | 0.063 0.044 DBMET00560 | DBMET00560 | |
| 0.056 | 0.062 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.091 0.04 DBMET00271 0.063 0.055 DBMET00326 0.08 0.045 DBMET00560 | DBMET00271 | |
| 0.117 | 0.123 | 0.181 | Death-associated protein kinase 1 inhibitor | 0.181 0.013 DBMET00535 | DBMET00535 | |
| 0.063 | 0.071 | 0.083 | Protein kinase B beta inhibitor | 0.083 0.039 DBMET00271 | DBMET00271 | |
| 0.036 | 0.045 | 0.044 | Stearoyl-CoA desaturase inhibitor | 0.044 0.03 DBMET00271 | DBMET00271 | |
| 0.096 | 0.105 | 0.104 | Epidermal growth factor receptor kinase inhibitor | 0.104 0.092 DBMET00271 | DBMET00271 | |
| 0.017 | 0.028 | 0.023 | Glutaminyl-peptide cyclotransferase inhibitor | 0.02 0.017 DBMET00271 0.023 0.013 DBMET00272 | DBMET00272 | |
| 0.043 | 0.054 | 0.058 | Phosphatidylinositol 3-kinase delta inhibitor | 0.058 0.039 DBMET00271 | DBMET00271 | |
| 0.185 | 0.197 | 0.34 | Antithrombotic | 0.205 0.171 DBMET00271 0.34 0.068 DBMET00535 0.271 0.11 DBMET00326 0.255 0.122 DBMET00560 | DBMET00535 | |
| 0.142 | 0.153 | 0.201 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.201 0.1 DBMET00272 0.198 0.101 DBMET00535 0.164 0.127 DBMET00326 0.164 0.126 DBMET00560 | DBMET00272 | |
| 0.078 | 0.089 | 0.189 | DNA directed RNA polymerase inhibitor | 0.115 0.041 DBMET00271 0.189 0.015 DBMET00272 0.094 0.064 DBMET00326 0.171 0.019 DBMET00560 | DBMET00272 | |
| 0.055 | 0.069 | 0.072 | CDK1/cyclin B1 inhibitor | 0.072 0.045 DBMET00271 0.064 0.055 DBMET00272 | DBMET00271 | |
| 0.081 | 0.096 | 0.13 | Anabolic | 0.13 0.031 DBMET00535 0.095 0.071 DBMET00326 | DBMET00535 | |
| 0.033 | 0.048 | 0.065 | Guanylate cyclase inhibitor | 0.065 0.008 DBMET00535 | DBMET00535 | |
| 0.082 | 0.097 | 0.106 | Cyclin-dependent kinase 2 inhibitor | 0.094 0.076 DBMET00271 0.106 0.063 DBMET00272 | DBMET00272 | |
| 0.044 | 0.06 | 0.081 | EphB4 antagonist | 0.081 0.023 DBMET00272 | DBMET00272 | |
| 0.076 | 0.092 | 0.143 | Ephrin antagonist | 0.143 0.039 DBMET00272 | DBMET00272 | |
| 0.054 | 0.071 | 0.065 | Sirtuin 1 inhibitor | 0.065 0.051 DBMET00272 | DBMET00272 | |
| 0.024 | 0.041 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET00272 | DBMET00272 | |
| 0.006 | 0.023 | 0.013 | Corticotropin releasing factor antagonist | 0.013 0.004 DBMET00535 | DBMET00535 | |
| 0.004 | 0.022 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 DBMET00560 | DBMET00560 | |
| 0.173 | 0.192 | 0.233 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.108 DBMET00326 0.233 0.086 DBMET00560 | DBMET00560 | |
| 0.04 | 0.061 | 0.079 | Acetylcholine muscarinic agonist | 0.053 0.04 DBMET00271 0.061 0.033 DBMET00326 0.079 0.023 DBMET00560 | DBMET00560 | |
| 0.187 | 0.209 | 0.248 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.248 0.068 DBMET00271 | DBMET00271 | |
| 0.071 | 0.093 | 0.099 | CDK2/cyclin A inhibitor | 0.099 0.058 DBMET00271 0.083 0.077 DBMET00272 | DBMET00271 | |
| 0.053 | 0.076 | 0.066 | Interferon inducer | 0.064 0.045 DBMET00272 0.06 0.054 DBMET00535 0.066 0.041 DBMET00560 | DBMET00560 | |
| 0.063 | 0.086 | 0.08 | Interferon agonist | 0.08 0.052 DBMET00272 0.074 0.062 DBMET00535 0.08 0.052 DBMET00560 | DBMET00560 | |
| 0.079 | 0.102 | 0.093 | Alpha 2b adrenoreceptor antagonist | 0.093 0.081 DBMET00271 | DBMET00271 | |
| 0.025 | 0.05 | 0.043 | Purinergic P2X3 antagonist | 0.043 0.014 DBMET00535 | DBMET00535 | |
| 0.047 | 0.072 | 0.056 | Purinergic P2X1 antagonist | 0.056 0.05 DBMET00272 | DBMET00272 | |
| 0.076 | 0.103 | 0.098 | Interleukin 1 beta converting enzyme inhibitor | 0.098 0.061 DBMET00535 0.088 0.075 DBMET00326 | DBMET00535 | |
| 0.061 | 0.09 | 0.079 | Bcr-Abl kinase inhibitor | 0.074 0.072 DBMET00271 0.079 0.066 DBMET00535 | DBMET00535 | |
| 0.042 | 0.072 | 0.058 | CDK1/cyclin B inhibitor | 0.058 0.048 DBMET00272 | DBMET00272 | |
| 0.071 | 0.102 | 0.158 | Bromodomain-containing protein 2 inhibitor | 0.099 0.041 DBMET00271 0.103 0.037 DBMET00272 0.099 0.042 DBMET00535 0.123 0.021 DBMET00326 0.158 0.007 DBMET00560 | DBMET00560 | |
| 0.047 | 0.079 | 0.151 | HIV-1 reverse transcriptase inhibitor | 0.116 0.024 DBMET00272 0.08 0.042 DBMET00326 0.151 0.014 DBMET00560 | DBMET00560 | |
| 0.055 | 0.092 | 0.081 | Phospholipase D inhibitor | 0.074 0.046 DBMET00326 0.081 0.033 DBMET00560 | DBMET00560 | |
| 0.087 | 0.124 | 0.146 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.07 DBMET00326 0.146 0.058 DBMET00560 | DBMET00560 | |
| 0.118 | 0.156 | 0.169 | DNA methylase inhibitor | 0.169 0.101 DBMET00272 0.155 0.113 DBMET00535 | DBMET00272 | |
| 0.149 | 0.192 | 0.248 | 5 Hydroxytryptamine 1E antagonist | 0.197 0.134 DBMET00272 0.231 0.096 DBMET00326 0.248 0.077 DBMET00560 | DBMET00560 | |
| 0.123 | 0.166 | 0.153 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.153 0.128 DBMET00271 | DBMET00271 | |
| 0.107 | 0.15 | 0.205 | Polo-like kinase-3 inhibitor | 0.163 0.071 DBMET00271 0.187 0.053 DBMET00326 0.205 0.042 DBMET00560 | DBMET00560 | |
| 0.112 | 0.158 | 0.135 | DNA methyltransferase I inhibitor | 0.135 0.122 DBMET00272 0.131 0.129 DBMET00535 | DBMET00272 | |
| 0.058 | 0.104 | 0.243 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.243 0.013 DBMET00271 0.083 0.069 DBMET00326 0.087 0.065 DBMET00560 | DBMET00271 | |
| 0.011 | 0.058 | 0.106 | Calcitonin gene-related peptide antagonist | 0.072 0.004 DBMET00271 0.031 0.015 DBMET00272 0.085 0.003 DBMET00326 0.106 0.003 DBMET00560 | DBMET00560 | |
| 0.066 | 0.112 | 0.135 | Mediator release inhibitor | 0.135 0.036 DBMET00535 | DBMET00535 | |
| 0.024 | 0.071 | 0.052 | Acetylcholine M1 receptor agonist | 0.052 0.025 DBMET00560 | DBMET00560 | |
| 0.013 | 0.061 | 0.028 | Acetylcholine M4 receptor agonist | 0.028 0.023 DBMET00560 | DBMET00560 | |
| 0.045 | 0.094 | 0.216 | Raf kinase inhibitor | 0.216 0.011 DBMET00271 0.077 0.047 DBMET00326 0.079 0.045 DBMET00560 | DBMET00271 | |
| 0.092 | 0.142 | 0.115 | Activin receptor-like kinase 2 inhibitor | 0.115 0.103 DBMET00271 | DBMET00271 | |
| 0.076 | 0.127 | 0.113 | Acetylcholine muscarinic antagonist | 0.113 0.074 DBMET00535 | DBMET00535 | |
| 0.077 | 0.128 | 0.11 | mTOR complex 1 inhibitor | 0.11 0.043 DBMET00271 | DBMET00271 | |
| 0.057 | 0.11 | 0.074 | ErbB-3 antagonist | 0.074 0.07 DBMET00535 | DBMET00535 | |
| 0.056 | 0.109 | 0.11 | Antiadrenergic | 0.11 0.05 DBMET00271 0.096 0.059 DBMET00560 | DBMET00271 | |
| 0.159 | 0.216 | 0.19 | Transcription factor NF kappa B inhibitor | 0.19 0.179 DBMET00535 | DBMET00535 | |
| 0.053 | 0.111 | 0.107 | Adrenaline antagonist | 0.107 0.05 DBMET00271 0.093 0.058 DBMET00560 | DBMET00271 | |
| 0.024 | 0.086 | 0.053 | Thymidylate synthase inhibitor | 0.053 0.024 DBMET00272 | DBMET00272 | |
| 0.035 | 0.097 | 0.087 | Acetylcholine M5 receptor agonist | 0.075 0.039 DBMET00326 0.087 0.028 DBMET00560 | DBMET00560 | |
| 0.009 | 0.073 | 0.02 | Geranylgeranyltransferase I inhibitor | 0.02 0.015 DBMET00535 | DBMET00535 | |
| 0.008 | 0.073 | 0.133 | Calcitonin gene-related peptide 1 receptor antagonist | 0.102 0.004 DBMET00271 0.119 0.003 DBMET00326 0.133 0.003 DBMET00560 | DBMET00560 | |
| 0.116 | 0.183 | 0.144 | Dyrk kinase inhibitor | 0.144 0.141 DBMET00271 | DBMET00271 | |
| 0.028 | 0.098 | 0.173 | Raf kinase B inhibitor | 0.173 0.011 DBMET00271 0.056 0.044 DBMET00326 0.056 0.044 DBMET00560 | DBMET00271 | |
| 0.054 | 0.125 | 0.117 | Protein kinase (CK2) inhibitor | 0.117 0.05 DBMET00272 | DBMET00272 | |
| 0.1 | 0.172 | 0.165 | LIM domain kinase 1 inhibitor | 0.165 0.084 DBMET00271 | DBMET00271 | |
| 0.118 | 0.191 | 0.201 | Immunostimulant | 0.197 0.122 DBMET00272 0.201 0.119 DBMET00535 | DBMET00535 | |
| 0.06 | 0.135 | 0.438 | Uric acid excretion stimulant | 0.137 0.028 DBMET00271 0.438 0.004 DBMET00560 | DBMET00560 | |
| 0.051 | 0.13 | 0.112 | Acetylcholine agonist | 0.092 0.053 DBMET00326 0.112 0.04 DBMET00560 | DBMET00560 | |
| 0.023 | 0.103 | 0.05 | Xanthine dehydrogenase inhibitor | 0.05 0.046 DBMET00271 0.05 0.046 DBMET00560 | DBMET00560 | |
| 0.068 | 0.15 | 0.217 | MAP kinase 12 inhibitor | 0.217 0.018 DBMET00271 0.111 0.082 DBMET00272 0.11 0.084 DBMET00326 0.151 0.041 DBMET00560 | DBMET00271 | |
| 0.009 | 0.092 | 0.035 | Uridine phosphorylase inhibitor | 0.035 0.014 DBMET00560 | DBMET00560 | |
| 0.019 | 0.104 | 0.045 | Purinergic P2Y2 antagonist | 0.034 0.022 DBMET00271 0.045 0.013 DBMET00272 0.041 0.015 DBMET00560 | DBMET00272 | |
| 0.064 | 0.15 | 0.168 | RET inhibitor | 0.168 0.053 DBMET00271 | DBMET00271 | |
| 0.138 | 0.225 | 0.231 | Thyroid hormone antagonist | 0.231 0.136 DBMET00535 | DBMET00535 | |
| 0.135 | 0.223 | 0.178 | MAP kinase kinase 5 inhibitor | 0.178 0.067 DBMET00535 | DBMET00535 | |
| 0.026 | 0.115 | 0.041 | Kainate receptor agonist | 0.041 0.029 DBMET00560 | DBMET00560 | |
| 0.091 | 0.181 | 0.152 | MAP3K9 inhibitor | 0.152 0.057 DBMET00271 | DBMET00271 | |
| 0.065 | 0.156 | 0.153 | Alkylator | 0.1 0.088 DBMET00271 0.113 0.075 DBMET00272 0.153 0.045 DBMET00560 | DBMET00560 | |
| 0.011 | 0.106 | 0.024 | Nicotinic acid receptor 2 antagonist | 0.024 0.023 DBMET00560 | DBMET00560 | |
| 0.14 | 0.235 | 0.301 | Beta lactamase inhibitor | 0.301 0.134 DBMET00535 0.223 0.171 DBMET00326 0.202 0.184 DBMET00560 | DBMET00535 | |
| 0.162 | 0.257 | 0.256 | 15-Lipoxygenase inhibitor | 0.251 0.164 DBMET00535 0.256 0.16 DBMET00326 | DBMET00326 | |
| 0.089 | 0.192 | 0.127 | Cyclin-dependent kinase 8 inhibitor | 0.127 0.108 DBMET00271 0.126 0.108 DBMET00560 | DBMET00271 | |
| 0.02 | 0.125 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.023 DBMET00272 | DBMET00272 | |
| 0.158 | 0.265 | 0.209 | 5 Hydroxytryptamine uptake stimulant | 0.193 0.167 DBMET00326 0.209 0.134 DBMET00560 | DBMET00560 | |
| 0.125 | 0.235 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET00272 | DBMET00272 | |
| 0.064 | 0.174 | 0.145 | Nav1.6 sodium channel blocker | 0.145 0.06 DBMET00326 0.139 0.068 DBMET00560 | DBMET00326 | |
| 0.154 | 0.266 | 0.242 | DNA polymerase beta inhibitor | 0.242 0.197 DBMET00535 0.219 0.211 DBMET00326 | DBMET00535 | |
| 0.125 | 0.239 | 0.214 | Thyroid hormone beta antagonist | 0.214 0.143 DBMET00535 | DBMET00535 | |
| 0.054 | 0.168 | 0.084 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.084 0.074 DBMET00560 | DBMET00560 | |
| 0.032 | 0.149 | 0.055 | Dihydroorotate oxidase inhibitor | 0.055 0.039 DBMET00560 | DBMET00560 | |
| 0.105 | 0.223 | 0.172 | ATPase inhibitor | 0.172 0.068 DBMET00535 0.156 0.092 DBMET00326 0.168 0.074 DBMET00560 | DBMET00535 | |
| 0.087 | 0.208 | 0.195 | Anesthetic general | 0.139 0.126 DBMET00271 0.135 0.131 DBMET00326 0.195 0.077 DBMET00560 | DBMET00560 | |
| 0.087 | 0.209 | 0.139 | Growth hormone agonist | 0.123 0.116 DBMET00326 0.139 0.097 DBMET00560 | DBMET00560 | |
| 0.082 | 0.205 | 0.119 | Mannose-6-phosphate isomerase inhibitor | 0.119 0.103 DBMET00560 | DBMET00560 | |
| 0.072 | 0.196 | 0.19 | Interleukin 1 antagonist | 0.19 0.037 DBMET00535 | DBMET00535 | |
| 0.046 | 0.182 | 0.081 | Prolactin inhibitor | 0.081 0.08 DBMET00560 | DBMET00560 | |
| 0.022 | 0.161 | 0.051 | CC chemokine 4 receptor antagonist | 0.051 0.026 DBMET00560 | DBMET00560 | |
| 0.048 | 0.19 | 0.065 | MDM2 inhibitor | 0.065 0.054 DBMET00560 | DBMET00560 | |
| 0.022 | 0.174 | 0.068 | Purinergic P2 antagonist | 0.068 0.04 DBMET00326 0.059 0.049 DBMET00560 | DBMET00326 | |
| 0.129 | 0.284 | 0.179 | Transcription factor STAT inhibitor | 0.179 0.169 DBMET00535 | DBMET00535 | |
| 0.13 | 0.286 | 0.28 | Immunosuppressant | 0.28 0.128 DBMET00535 | DBMET00535 | |
| 0.044 | 0.204 | 0.128 | Glycogen synthase kinase-3 alpha inhibitor | 0.128 0.079 DBMET00271 0.107 0.097 DBMET00272 | DBMET00271 | |
| 0.124 | 0.289 | 0.212 | Peptidyltransferase inhibitor | 0.212 0.085 DBMET00272 0.185 0.12 DBMET00326 0.201 0.097 DBMET00560 | DBMET00272 | |
| 0.018 | 0.183 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 DBMET00560 | DBMET00560 | |
| 0.039 | 0.207 | 0.091 | Glycogen synthase kinase-3 beta inhibitor | 0.091 0.09 DBMET00271 | DBMET00271 | |
| 0.042 | 0.212 | 0.115 | Protein-tyrosine kinase Lyn inhibitor | 0.115 0.089 DBMET00271 | DBMET00271 | |
| 0.047 | 0.218 | 0.129 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.129 0.075 DBMET00272 | DBMET00272 | |
| 0.161 | 0.341 | 0.279 | Cyclophilin D inhibitor | 0.279 0.182 DBMET00535 | DBMET00535 | |
| 0.03 | 0.212 | 0.053 | Pregnane X receptor antagonist | 0.053 0.05 DBMET00560 | DBMET00560 | |
| 0.023 | 0.21 | 0.133 | Check point kinase 1 inhibitor | 0.12 0.02 DBMET00271 0.099 0.029 DBMET00326 0.133 0.017 DBMET00560 | DBMET00560 | |
| 0.056 | 0.248 | 0.119 | Interleukin 12 antagonist | 0.119 0.03 DBMET00535 | DBMET00535 | |
| 0.014 | 0.206 | 0.048 | Bromodomain-containing protein 3 inhibitor | 0.048 0.036 DBMET00560 | DBMET00560 | |
| 0.018 | 0.261 | 0.12 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.116 0.029 DBMET00271 0.085 0.046 DBMET00326 0.12 0.027 DBMET00560 | DBMET00560 | |
| 0.085 | 0.352 | 0.301 | Alpha-glucosidase inhibitor | 0.301 0.159 DBMET00326 | DBMET00326 | |
| 0.005 | 0.286 | 0.035 | Purinergic P2Y12 antagonist | 0.02 0.019 DBMET00271 0.032 0.011 DBMET00326 0.035 0.01 DBMET00560 | DBMET00560 | |
| 0.027 | 0.342 | 0.122 | I kappa B kinase 1 inhibitor | 0.122 0.014 DBMET00535 | DBMET00535 | |
| 0.037 | 0.401 | 0.216 | Nav1.1 sodium channel blocker | 0.216 0.016 DBMET00326 0.197 0.019 DBMET00560 | DBMET00326 | |
| 0.029 | 0.504 | 0.095 | Interleukin 5 antagonist | 0.095 0.048 DBMET00272 | DBMET00272 | |
| 0.015 | 0.571 | 0.143 | Lipid peroxidase inhibitor | 0.143 0.073 DBMET00326 0.124 0.089 DBMET00560 | DBMET00326 | |
| 0.013 | 0.684 | 0.057 | Sodium/calcium exchanger inhibitor | 0.057 0.022 DBMET00560 | DBMET00560 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |